The Best Sleepwear May be No Sleepwear. Here’s What Experts Say

The Best Sleepwear May be No Sleepwear. Here’s What Experts Say

Claremont Colonic Center
If you have ever tossed and turned under heavy blankets, you’ve felt firsthand how being too warm can wreck your sleep.
“Temperature is one of the most underappreciated factors in sleep,” said Joseph Dzierzewski, senior vice president of research and scientific affairs at the National Sleep Foundation. “We often hear about light, screens and stress, but even modest changes in temperature and airflow can influence how quickly you fall asleep and how deeply you stay asleep.”

Your core body temperature naturally drops by about 1 to 2 degrees Fahrenheit (about 0.6 to 1 degree Celsius) to fall asleep, he said, and if that cooling process is disrupted even slightly, sleep can become more fragmented and less restorative.

The most important thing is creating what Dzierzewski calls a comfortable sleep microclimate, in which your body isn’t trapping heat between your skin, sleepwear and bedding.

“For some people, that may mean sleeping naked or with minimal clothing; for others, lightweight, moisture-wicking fabrics work well,” he said. The goal is to feel comfortable and secure while helping your body cool naturally.

For Brian Diva Cox in Portland, Oregon, that microclimate is easiest to achieve without pajamas. He said sleeping naked became a nightly habit in his teens and, while it’s more occasional now as an adult, he still does it when he wants to prioritize comfort and recovery — especially on nights when time is short.

“I wake up refreshed,” he said, adding that he invariably has energy and his smart watch’s sleep chart shows his improved sleep quality the next day.

Whether you ditch your pajamas or simply switch to lighter layers, reducing insulation can make it easier for your body to release heat. Interestingly, Dzierzewski also noted that warming the hands and feet before bed can help the body release heat more efficiently and fall asleep faster. For people who naturally have cold extremities, keeping them comfortably warm during sleep can also help maintain more stable sleep.

How much moisture there is in the air matters, too.

“High humidity limits your body’s ability to cool itself through sweat,” he said, so using breathable, moisture-wicking materials in mattresses, bedding and sleepwear can all help your body offload the heat.

Keeping a cooler room, typically around 60 to 67 degrees Fahrenheit (around 15 to 19 degrees Celsius) with good airflow, can also support that process, Dzierzewski explained. Be flexible with those temperatures, since comfort can vary by person and people who sleep hot or are experiencing hormonal changes tend to prefer the cooler end of the range.

Finally, it’s not just about setting a cooler temperature — it’s about keeping it consistent through the night. Big swings can trigger middle-of-the-night wake-ups if you start overheating.

Cooler temps can also impact sperm production

Temperature doesn’t just affect sleep quality — it plays a role in reproductive health, too.

“The testes are outside the body for a reason — optimal sperm production requires temperatures a few degrees below core body temp,” said CNN contributor Dr. Jamin Brahmbhatt, a urologist and robotic surgeon with Orlando Health. That’s why what you choose to wear or not wear to bed can matter.

Brahmbhatt, who is also an assistant professor at the University of Central Florida’s College of Medicine, also referenced a large Harvard University study that showed men who wore boxers had higher sperm concentration than those who wore formfitting styles. But he said the key factor is not the tightness itself, but the heat.

“Tight underwear traps heat against the body,” he explained, echoing the same reasoning around warnings about hot tubs and laptops — the excessive heat. “It’s less about compression and more about the level of insulation,” he said.

The takeaway? Sleeping cooler — whether naked or in breathable clothing — may help reduce heat buildup overnight. Better sleep itself may also support hormone health.

“When men sleep better, testosterone production improves,” he added. Because testosterone is primarily produced during sleep, deeper, more restorative rest can support energy, mood and sexual function. Better sleep leads to a better hormonal balance, which supports libido, he said.

“You don’t have to sleep naked to get these benefits. You just have to sleep cool,” he added. If you do choose to skip the clothes, he advised that it’s important to wash your sheets more frequently.

Intimacy without pressure

Sleeping naked or in minimal clothing with your partner may have perks beyond temperature control.

For some couples, cuddling skin-to-skin becomes a “way of feeling connected and close,” said CNN contributor Ian Kerner, a licensed marriage and family therapist. It doesn’t have to be sexual, he added, but it can help keep a sense of connection alive — and it sometimes creates more opportunity for sex when couples arrive in bed exhausted.

Even when it doesn’t lead to sex, the contact itself can be meaningful. Skin-to-skin touch is associated with oxytocin, a hormone linked to bonding and emotional closeness, he said.

“This is a nice way of showing up in bed without having sexual desire — but potentially getting to desire,” Kerner said. “The couples that I work with who sleep naked, they like it. It becomes a ritual.”

Having the conversation with your partner before you go “no PJs” is critical, and Kerner shared some tips on how to broach the topic. One approach you could take is light and fun, saying “I am going to be sleeping naked tonight. Care to join me?” he said, emphasizing that this doesn’t have to be a sexual thing. Another way is expressing to your partner that you miss intimacy or feeling close and offering getting in bed naked as an option to feel more connected, he said.

For couples trying to reconnect, he sometimes suggests what he calls a “willingness window” — a low-pressure way to prioritize closeness. Partners do not need to show up with desire, just willingness. “Sleeping side by side naked could be a first step,” he said. “You don’t have to make it a habit — even once a week, just to see how it feels.”

While Kerner doesn’t see sleeping naked as a requirement, it could be used as an excuse to get in bed and be naked and without our phones and be human with each other for a little while, he said.

Whether you are ditching pajamas entirely or just switching to lighter fabrics, the goal is the same — helping your body cool down, sleep more deeply and, potentially, feel a little more connected in the process. If you do choose to sleep naked, make sure to keep clothes handy in case of emergencies.


Contributor: Lily Hautau – CNN Health

Adding Seafood to Your Diet Reduces Your Risk of Dying from Heart Disease

Adding Seafood to Your Diet Reduces Your Risk of Dying from Heart Disease

Claremont Colonic Center Newsletter
If you’re like most Americans, you’re not getting the recommended eight ounces of seafood per week; fewer than 22 percent meet this goal. And you may be missing out on an important strategy to improve your health through diet.
Seafood is a low-saturated-fat protein choice, rich in beneficial nutrients, including vitamin D, selenium and omega-3 fatty acids. Aim for at least two servings of protein-rich, low-saturated-fat seafood every week to boost heart and brain health and enhance mood.

Fishing for Healthy Nutrients

Strong evidence indicates eicosapentanenoic acid (EPA) and docosahexaenoic acid (DHA,) the essential omega-3 fats in fish, can boost heart health, as well as offer protection against depression, dementia and inflammatory disorders, such as asthma and rheumatoid arthritis.

The Dietary Reference Intake (DRI, a daily guide for intake) for omega-3 fats has not been established to date; however, the American Heart Association recommends a total of one gram of EPA plus DHA per day, preferably from oily fish, for those with heart disease. The adult DRI for vitamin D is 600 International Units, and for selenium, 55 micrograms.

Inadequate vitamin D intake is a widespread problem that may increase the risk of several diseases, including osteoporosis, infectious disease, heart disease, cancer, and seasonal flu. Poor selenium intake is linked with autism, Alzheimer’s disease, rheumatoid arthritis, and asthma.

A Sea of Benefits

Here’s a look at the latest evidence on seafood and health:

1. Heart health. Both the U.S. Department of Agriculture’s Dietary Guidelines for Americans 2010 and the American Heart Association recommend that you eat at least two servings of fish each week. Research shows that regular consumption of fish reduces the risk of dying from heart disease by 36 percent.

2. Pregnancy. The intake of omega-3s during pregnancy plays an important role in infant brain development and health. This is why the Dietary Guidelines call for women who are pregnant or breastfeeding to eat eight to 12 ounces of seafood per week. According to U.S. seafood consumption statistics, most pregnant women do not consume the recommended intake of seafood, thus they are not likely to obtain enough omega-3s in their diet.

Concerns about mercury contamination have led to both fear and confusion regarding the safety of eating fish during pregnancy. However, it’s been established that benefits outweigh potential risks.

3. Mood and brain health. It’s no surprise that seafood, a rich source of omega-3, has earned a reputation as “brain food.” Research continues to illustrate possible benefits of omega-3s in the treatment of mental disorders, including depression, Alzheimer’s disease, and neuropsychiatric disorders.

DHA is a major structural fat in the human brain, representing about 97 percent of all the brain’s omega-3 fats, and plays an important role in memory, brain performance, and behavioral function.

Benefits Outweigh Potential Risks

With so many benefits linked with eating seafood, why are people missing out on this opportunity for better health? Sylvia Geiger, M.S., R.D., registered dietitian specializing in seafood and health, spoke at the Supermarket RD Symposium in Savannah, Ga., in March.

“The nutritional benefits are overshadowed by fear of environmental contaminants, including methylmercury, dioxins and polychlorinated biphenyls (PCBs) potentially found in seafood sources, and confusion about sustainability,” Geiger reported.

But a 2006 study published in the Journal of the American Medical Association by Harvard researchers provided a poignant example quantifying the potential health benefits vs. risks for consuming seafood: The study projected that if 100,000 people ate farmed or wild salmon twice a week for 70 years, nearly 7,100 lives might be saved as a result of cardiovascular disease protection.

At the same time, only 24 deaths might result due to exposure to potential contaminants. The researchers concluded that it is far riskier to forgo the healthful nutrients derived from eating seafood than it is to avoid seafood due to fear of contaminants.

If your body has sufficient selenium to maintain proper function, the risks for mercury are mitigated, according to the Energy and Environmental Research Center, Grand Forks, N.D. Seafood is among 17 of the top 25 sources of dietary selenium consumed in the U.S.; thus, people who maintain optimal intake levels of selenium may reduce their risk of mercury exposure.


Contributor: – Barbara Ruhs, M.S., R.D., L.D.N., – Alternative Daily

Trader Joe’s Recalls 10 Million More Pounds of Frozen Food in 43 States

Trader Joe’s Recalls 10 Million More Pounds of Frozen Food in 43 States

Claremont Colonic Trader Joes Recall

Fried rice, ramen and dumpling products sold nationwide have been recalled from the popular grocer.

Trader Joe’s is expanding its ongoing recall of multiple frozen food products that are sold in its stores.

In February, food supplier Ajinomoto Foods North America Inc. first recalled over three million pounds of frozen, not ready-to-eat chicken fried rice products, per the U.S. Department of Agriculture’s Food Safety and Inspection Service (FSIS).

The recall was expanded on March 3 to include more than 33 million additional pounds of “various ready-to-eat and not ready-to-eat chicken and pork fried rice, ramen, and shu mai dumpling products,” per the FSIS.

As of March 20, the food supplier has expanded the recall once again to include nearly 10 million additional pounds of food.

Below, we’re sharing everything you need to know about the ongoing recall.

What Has Been Recalled?

February 19 Recall


On Feb. 19, 2026, Ajinomoto Foods North America Inc. recalled approximately 3,370,530 pounds of the following frozen food products sold at Trader Joe’s:

Ajinomuoto Yakitori Chicken with Japanese-Style Fried Rice:
  • 1.53-kilogram cardboard packages containing six bags
  • Best before date of Sept. 9, 2026 through Nov. 12, 2026


Trader Joe’s Chicken Fried Rice with Stir Fried Rice, Vegetables, Seasoned Dark Chicken Meat and Eggs:
  • 20-ounce plastic bag packages
  • Best by dates of Sept. 8, 2026 through Nov. 17, 2026

All of the recalled products were produced between Sep. 8, 2025 and Nov. 17, 2025. They all feature the establishment number P-18356 inside the USDA mark of inspection.

The Trader Joe’s item was shipped to Trader Joe’s stores nationwide, while the Ajinomoto product was only exported to Canada.

March 3 Recall

On March 3, 2026, Trader Joe’s posted a notice to its website related to Ajinomoto’s ongoing recall. In its message, the retailer announced that it was recalling certain Trader’s Joe frozen products “in an abundance of caution.”

The recall was expanded to include the following products:

  • Chicken Fried Rice: Best by dates between March 4, 2026 — Feb. 10, 2027
  • Vegetable Fried Rice: Best by dates between Feb. 28, 2026 — 0 Nov. 19, 2026
  • Japanese Style Fried Rice: Best by dates between Feb. 28, 2026 — Nov. 14, 2026
  • Chicken Shu Mai: Best by dates between March 13, 2026 — 03/ Oct. 23, 2026


March 20 Recall

On March 20, the U.S. Food and Drug Administration (FDA) posted a notice to is website to share an update on the ongoing recall.

The FDA shared that Ajinomoto had added 9,885,240 pounds of frozen food products, including the following:

Trader Joe’s Vegetable Fried Rice

  • Item #5650233
  • Each case of 24 includes 1-pound bags
  • UPC #00521482
  • Case UPC # 10052148200001
  • Best by date ranges listed here


Per the FDA, the products were distributed to the following states: Alaska, Alabama, Arkansas, Arizona, California, Colorado, Connecticut, Delaware, Florida, Georgia, Idaho, Illinois, Indiana, Kansas, Kentucky, Louisiana, Massachusetts, Maryland, Michigan, Minnesota, Missouri, Mississippi, Montana, North Carolina, North Dakota, Nebraska, New Hampshire, New Jersey, Nevada, New York, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, Tennessee, Texas, Utah, Virginia, Washington, Wisconsin and Wyoming.

Why Are the Products Being Recalled?

All of the affected products have been recalled due to concerns that they may be contaminated with glass.

Per the FSIS, the issue was initially discovered after four consumers reported finding glass in the products. So far, there are no confirmed reports of injury.

What to Do If You Have the Recalled Products at Home

Consumers who have any of the affected products at home are encouraged to throw them away or return them to Trader Joe’s for a refund.


Contibutor: Chrissy Callahan – Today.com

Weight-Loss Treatment is on the Verge of a Dramatic Shift – Again

Weight-Loss Treatment is on the Verge of a Dramatic Shift - Again

Claremont Colonic Center
At the end of a seemingly ubiquitous commercial for telehealth company Ro, a characteristically flabbergasted Charles Barkley speaks for us all when he remarks, “Wait, you’re telling me they have a GLP-1 pill for weight loss now?”
They do – and it turns out to be as wildly popular as its injectable predecessors. Just about 10 weeks after it was approved by the US Food and Drug Administration, the Wegovy pill is now estimated to be part of the daily regimen of about 400,000 Americans. And the field of weight-loss treatment is on the verge of even more head-spinning change.

A second pill is under review at the FDA, expected to hit the market as soon as next month, and many more are in clinical trials. Some companies are testing drugs that only need to be taken once a month. And an even more powerful next generation of medicines is quickly approaching, churning out trial results – including some new ones Thursday – that leave current options in the dust in terms of efficacy.

“We are entering this kind of phase two of using the GLP-1 system,” said Dr. Jody Dushay, an endocrinologist at Beth Israel Deaconess Medical Center and assistant professor at Harvard Medical School.

The next wave could be driven by cost and convenience as much as by new approaches to treatment. The weight-loss pills – the one already on the market and the one waiting to be approved – have brought prices to new lows for US patients in a deal that both drugs’ makers struck with the Trump administration, even as insurance coverage can remain spotty for many.

And the more powerful drugs on the horizon could bring options for people who don’t get enough benefit from currently available therapies – but also, doctors warned, the risk of inappropriate use.

‘Triple G’

One such drug is retatrutide, a weekly injectable medicine in development at Eli Lilly, which also makes Mounjaro for diabetes and Zepbound for weight loss.

Those drugs are based on the active ingredient tirzepatide, which mimics two hormones: GLP-1 and GIP. Retatrutide ups the ante by adding a third, called glucagon, earning it the moniker “Triple G.”

It’s breaking records for weight loss induced with medicines; in clinical trial results reported in December, retatrutide led to average loss of up to 29% of participants’ body weight after 68 weeks, or about 71 pounds, in a study of people with knee osteoarthritis. The drug was also associated with reduced knee pain.

In new results released Thursday on type 2 diabetes, with which patients tend to lose less weight with medications, Lilly said the drug lowered A1C blood sugar levels by an average of 1.7% to 2% at 40 weeks and produced average weight loss of up to 17%, or about 37 pounds. That exceeds results for Mounjaro, which showed an average A1C reduction of 1.7% and weight loss of about 9% at the highest dose in a separate trial.

“It’s looking like perhaps we are approaching another level” with drugs like retatrutide, said Dr. Judith Korner, an endocrinologist and director of the Metabolic and Weight Control Center at Columbia University Vagelos College of Physicians and Surgeons.

Novo Nordisk, which competes with Lilly with its drugs Ozempic and Wegovy, is in the Triple G game as well, reporting average weight loss of almost 20% after 24 weeks in a mid-stage study of another experimental drug in China last month.

The company’s higher-dose version of Wegovy won FDA approval Thursday, based on trial results showing average weight loss of 21% over 72 weeks, putting it in the same league as Lilly’s Zepbound. Novo Nordisk said the weekly injectable drug would be available as a single-dose pen in the US in April, and hasn’t yet announced its price.

The company is also pursuing other approaches, including a drug called CagriSema that combines semaglutide – the active ingredient in Ozempic and Wegovy – with cagrilintide, which targets another hormone called amylin. But in clinical trials, it hasn’t kept up with Lilly’s tirzepatide, much less retatrutide, although Novo Nordisk is testing higher doses.

Still, while the new combinations “would be great for people who need to lose more weight,” Korner said, “not everyone needs the so-called big gun.”

Drugs like retatrutide may be most appropriate for someone who has a body mass index above 45 – above 30 is considered obese – and for whom existing drugs haven’t worked sufficiently, Dushay said.

She estimates that about 10% of her patients either don’t get enough benefit from current medicines or can’t tolerate the side effects, which typically are gastrointestinal in nature, including nausea and vomiting.

Retatrutide has shown similar side effects, as well as a prickling sensation known as dysesthesia. And some participants have dropped out of retatrutide trials because they felt that they lost too much weight.

“There are these cases where retatrutide will be able to really make a difference,” Dushay said. But she worries that its souped-up results could be dangerous if it’s used inappropriately.

“What’s going to happen if people take it for just a little bit of weight loss?” she asked. Already, “you’re starting to see some Hollywood images of body types that are so shocking. So there is a little bit of concern about that.” It’s a concern that has been pervasive enough for existing drugs that Lilly released a commercial ahead of the 2024 Oscars urging against “vanity” use.

That was at a time when the drugs’ supply was a problem. “It matters who gets them,” the ad’s tagline said.

Now, supply is ramped up, including for pill versions of GLP-1s that are also changing the treatment landscape.

Two new weight-loss pills

The Wegovy pill was approved in December, and the speed with which people started using it broke records, according to one Wall Street firm, which said it became the fastest drug launch in history. Some analyses of early uptake show that it’s enticing at least some users who haven’t tried GLP-1 therapies before, suggesting that some may have preferred a noninjectable option. Many of the new prescriptions have been written by general practitioners, rather than weight-loss specialists.

But the Wegovy pill isn’t expected to be alone on the market for long. Eli Lilly – continuing a nearly century-long duel with Novo Nordisk that began with insulin and is escalating with GLP-1s – anticipates FDA approval of its own pill, called orforglipron, before the end of June.

A key differentiator is that it can be taken at any time of day, with or without food and drink, whereas the Wegovy pill has more restrictions. Since the latter is a version of semaglutide, which is typically given by injection, it’s been specially formulated to be taken orally. Thus it’s finickier than a typical pill: It must be taken first thing in the morning, with just a small amount of water, and no food, drinks or other medicines for at least 30 minutes.

For that reason, Korner said, orforglipron will be her go-to choice for people who decide they want to take a GLP-1 pill. “If you don’t take the Wegovy pill just right, very little of the drug is actually absorbed,” Korner said. “So it’s better to be able to remove that from the equation and not have to worry, ‘is my patient taking the pill correctly?’”

Changes in affordability

Cost is an important consideration as well, and there too, the weight-loss drug space has seen rapid transformation. The pills are priced at $149 a month for the lowest doses if patients pay out of pocket, through a deal struck with the Trump administration in November through its TrumpRx drug pricing initiative.

The companies also offer direct-pay prices for the injectable drugs, but they still cost hundreds of dollars a month out of pocket. Still, those prices can be the best for people whose insurance won’t cover the medicines, which can still be a major problem, Dushay said.

This year, Blue Cross Blue Shield of Massachusetts announced that it would stop covering GLP-1s for obesity, saying the drugs’ costs were driving insurance premiums too high. It suggested that patients consider buying the drugs directly from manufacturers.

Medicare is a brighter spot, expanding coverage for some patients as part of the November deal, but still doesn’t cover weight-loss drugs for all who might want them.

Trouble with insurance coverage is a key reason Dushay said she’s seen patients switch to the Wegovy pill. And although orforglipron is expected to get the same starting price, if there’s a differential, Korner said, that could be a deciding factor for her.

“If they’re paying out of pocket and one is less expensive than the other and I think that they both are probably as good,” she said, “then I would switch.”


Contributor: Meg Tirrell – CNN Health